{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:10:52Z","timestamp":1791173452022,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jaci.2011.08.036","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T14:21:39Z","timestamp":1318861299000},"page":"128-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"title":["Epicutaneous allergen-specific immunotherapy ameliorates grass pollen\u2013induced rhinoconjunctivitis: A\u00a0double-blind, placebo-controlled dose escalation study"],"prefix":"10.1016","volume":"129","author":[{"given":"Gabriela","family":"Senti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seraina","family":"von Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodor","family":"Sonderegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"K\u00fcndig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2011.08.036_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2500\/aap.2007.28.2934","article-title":"The burden of allergic rhinitis","volume":"28","author":"Nathan","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2011.08.036_bib2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaci.2006.02.040","article-title":"Sublingual immunotherapy: a comprehensive review","volume":"117","author":"Cox","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib3","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1185\/03007995.2010.528647","article-title":"Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe","volume":"26","author":"Cox","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaci.2011.08.036_bib4","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1016\/j.jaci.2009.10.064","article-title":"Allergen immunotherapy","volume":"125","author":"Frew","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nri2262","article-title":"Treatment strategies for allergy and asthma","volume":"8","author":"Holgate","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1067\/mai.2003.129","article-title":"Noninjection routes for immunotherapy","volume":"111","author":"Canonica","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib7","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2174\/138945009789753237","article-title":"Advances in allergen-specific immunotherapy","volume":"10","author":"Passalacqua","year":"2009","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jaci.2011.08.036_bib8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0091-6749(98)70271-4","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. A\u00a0WHO position paper","volume":"102","author":"Bousquet","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2009.02309.x","article-title":"Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009","volume":"64","author":"Canonica","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.08.036_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1081-1206(10)60259-1","article-title":"Comparison of allergen immunotherapy practice patterns in the United States and Europe","volume":"103","author":"Cox","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaci.2010.06.045","article-title":"How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers\u2019 viewpoint","volume":"126","author":"Senna","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","article-title":"Immune surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib13","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaci.2009.07.019","article-title":"Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy","volume":"124","author":"Senti","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib14","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1398-9995.2011.02560.x","article-title":"Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?","volume":"66","author":"Senti","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.08.036_bib15","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.vaccine.2008.02.070","article-title":"Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch","volume":"26","author":"Frerichs","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2011.08.036_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archopht.1990.01070030090035","article-title":"Conjunctival allergen challenge: a clinical approach to studying allergic conjunctivitis","volume":"108","author":"Abelson","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaci.2011.08.036_bib17","first-page":"S1","article-title":"Allergy diagnostic testing: an updated practice parameter","volume":"100","author":"Bernstein","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2009.10.060","article-title":"Speaking the same language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System","volume":"125","author":"Cox","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1398-9995.2006.01276.x","article-title":"Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines","volume":"62","author":"Bousquet","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.08.036_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/ACI.0b013e32832aef57","article-title":"Clinical outcome measures of specific immunotherapy","volume":"9","author":"Pfaar","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib21","first-page":"52","article-title":"Non-fatal systemic reactions to subcutaneous immunotherapy: a 20-year experience comparison of two 10-year periods","volume":"36","author":"Ragusa","year":"2004","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib22","first-page":"CD001936","article-title":"Allergen injection immunotherapy for seasonal allergic rhinitis","author":"Calderon","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2011.08.036_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000210380","article-title":"Elevated peripheral allergen-specific T cell response is crucial for a positive atopy patch test reaction","volume":"150","author":"Johansson","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib24","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1398-9995.2006.01136.x","article-title":"EAACI\/GA2LEN position paper: present status of the atopy patch test","volume":"61","author":"Turjanmaa","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.08.036_bib25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrd2653","article-title":"Therapeutic manipulation of immune tolerance in allergic disease","volume":"8","author":"Akdis","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2011.08.036_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2249.2010.04148.x","article-title":"T-cell responses induced by allergen-specific immunotherapy","volume":"161","author":"Maggi","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jaci.2007.06.013","article-title":"Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation","volume":"120","author":"Bohle","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/eji.200322919","article-title":"IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy","volume":"33","author":"Jutel","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib29","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.jaci.2008.03.013","article-title":"Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa","volume":"121","author":"Radulovic","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0091-6749(95)70172-9","article-title":"Atopy patch test with different vehicles and allergen concentrations: an approach to standardization","volume":"95","author":"Darsow","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.036_bib31","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(08)60839-9","article-title":"Use of a patch containing heat-labile toxin from Escherichia coli against travellers\u2019 diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial","volume":"371","author":"Frech","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2011.08.036_bib32","doi-asserted-by":"crossref","first-page":"e10818","DOI":"10.1371\/journal.pone.0010818","article-title":"Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial","volume":"5","author":"Combadiere","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2011.08.036_bib33","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.08.036_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2009.11.010","article-title":"Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study","volume":"104","author":"Hankin","year":"2010","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911014047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911014047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:32:28Z","timestamp":1758789148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674911014047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0091674911014047"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2011.08.036","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14264099.15777229","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epicutaneous allergen-specific immunotherapy ameliorates grass pollen\u2013induced rhinoconjunctivitis: A\u00a0double-blind, placebo-controlled dose escalation study","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2011.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}